Literature/202311281010 states are investing in lowering risks

First published:

Last Edited:

Number of edits:

Given that venture capital joins projects once the risk is between their tolerable levels, governments have been taking the role of investing in risk reduction until the private sector can take over.

This is very clear with the development of new medicines. Although big pharma should have the resources to push new drugs to market, the book argues that the stage at which they step in has been delaying over time.

It is a bit unclear what is cause and what is effect, and what are the economic incentives at play that would push pharma to take on larger risks at the sacrifice of income.

The author argues that states should focus on making thing happen that would not have otherwise.


Backlinks

These are the other notes that link to this one.

Nothing links here, how did you reach this page then?

Comment

Share your thoughts on this note. Comments are not public, they are messages sent directly to my inbox.
Aquiles Carattino
Aquiles Carattino
This note you are reading is part of my digital garden. Follow the links to learn more, and remember that these notes evolve over time. After all, this website is not a blog.
© 2024 Aquiles Carattino
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
Privacy Policy